News blog

LiDCO Group

  • BY: Andrew Hore |
  • POSTED: 22/07/2019 |

LiDCO Group has received approval in China for its LiDCOrapidhaemodynamic monitor. 

This means that it can be relaunched later this year. The approval was required because of the need to register a key component of the monitor and this held back sales in the past two years. China is the second largest market in the world.

Annual sales could exceed £500,000. There is little in the current forecasts for revenues from China. The group loss is expected to decline from £2m to £1.1m this year.

© 2019 Aim Micro. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

News Blog
All micro news

Northern Bear

Roofing and building services provider Northern Bear directors say they will not accept the 72p a share tender offer from Cedarvale Holdings. 

Continue reading... | 21/10/2019

LiDCO Group

Patient monitoring devices supplier LiDCO increased its product revenues by 10% in the year to July 2019. 

Continue reading... | 21/10/2019

Quoted Micro 14 October 2019

Continue reading... | 14/10/2019

Hague and London Oil

Former Aim company Hague and London Oil reported a decline in revenues in the first half of 2019, but it moved from loss to profit, but this was due to a gain on derivative instruments. 

Continue reading... | 13/10/2019

All micro news

Browse by issue
All issues
Popular tags
All tags

betbrokers, financial, gold, health, leisure, media, mobile, resources, services, technology

AIM Micro feeds

Keep up to date with articles published at AIMMicro.com. Subscribe to AIM Micro RSS Feeds